This collection of information is required by 35 U.S.C 156 and Administered through 37 CFR 1.710 through 1.791. The USPTO, together with the Sec. of Health & Human Servies and the Dept. of Agriculture, administers 35 U.S.C. 156 (Federal Food Drug, and Cosmetic Act), which permits the USPTO to restore the patent term lost due to certain types of regulatory review by the Federal Food and Drug Administration or the Dept. of Agriculture. The USPTO and the public use the information to extend the patient term past its original expiration date; to petition for review of informal extensions of applications, final eligibility .........
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.